Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The first GLP-1 (glucagon-like peptide-1) agonist drug approved by the FDA was exenatide
Injection-site reactions including pain and erythema occur in more than 1 in 10 patients and are listed as very common adverse effects in the Summary of Product Characteristics
Synthesis and in vitro evaluation of a peptidomimetic inhibitor targeting the Src homology 2 (SH2) domain of STAT6
doi: 10.1039/D2FO00357K 261 XiJZhangZWangZWuQHeYXuYet al
US$ 27.73
US$ 22.90
US$ 22.74
US$ 23.05
US$ 22.60
US$ 21.54
